Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis

度洛西汀 医学 血糖性 内科学 安慰剂 盐酸度洛西汀 糖尿病 临床终点 纤维肌痛 随机对照试验 重性抑郁障碍 内分泌学 替代医学 病理 扁桃形结构
作者
Antonio Crucitti,Qi Zhang,Mary Nilsson,Stephan Brecht,Charles R. Yang,Joachim Wernicke
出处
期刊:Current Medical Research and Opinion [Taylor & Francis]
卷期号:26 (11): 2579-2588 被引量:22
标识
DOI:10.1185/03007991003769241
摘要

OBJECTIVE: Mood disorders are often associated with poor glycemic control, and antidepressant treatments for mood and pain disorders can alter plasma glucose levels in patients with diabetes. A previous meta-analysis from three studies showed that duloxetine modestly increased fasting plasma glucose (FPG) and HbA(1c) levels in patients with diabetic peripheral neuropathic pain (DPNP). This meta-analysis examined whether there were any short- and long-term effects of duloxetine (20-120 mg/day) on glycemic control in patients with diagnoses other than DPNP. RESEARCH DESIGN AND METHODS: Short-term data (9-27 weeks): seven studies of duloxetine in general anxiety disorder, fibromyalgia, and chronic lower back pain (CLBP). Long-term data: 41-week, uncontrolled extension of the short-term CLBP study and 52-week study in patients with recurrence of major depressive disorder. MAIN OUTCOME MEASURES: Baseline-to-endpoint changes in FPG and HbA(1c) levels. RESULTS: In short-term studies, patients were randomly assigned to placebo (n = 1098) or duloxetine (n = 1563). Mean baseline-to-endpoint changes in FPG and HbA(1c) did not significantly differ in duloxetine-treated patients compared with placebo-treated patients. In the 41-week study (n = 181), duloxetine-treated patients experienced a small but significant within-group baseline-to-endpoint increase in HbA(1c) (mean change = 0.1%; p < 0.001). This result was in contrast to absence of effect on mean baseline-to-endpoint within-group changes in FPG (p = 0.326) in that study, and to absence of between-treatment changes in FPG (p = 0.744) and HbA(1c) (p = 0.180) in the 52-week placebo-controlled study. CONCLUSION: Duloxetine treatment did not significantly alter FPG and HbA(1c) levels compared with placebo treatment in the short-term studies. A small but statistically significant within-group increase in HbA(1c) was found in the 41-week study, but not in between-treatment group differences in the 52-week study. Neither of the long-term studies showed significant changes in the FPG levels. The small, non-reproducible HbA(1c) increase in one study of patients without DPNP may have resulted from patients with unrecognized diabetes in these trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
哈哈哈哈发布了新的文献求助10
刚刚
可爱的函函的应助被嘟嘟采纳,获得10
刚刚
LIuvia发布了新的文献求助10
刚刚
gxgxnn发布了新的文献求助10
1秒前
luf完成签到,获得积分10
1秒前
Goxan完成签到,获得积分10
1秒前
xinyang发布了新的文献求助10
1秒前
if的应助被流年采纳,获得10
2秒前
风华发布了新的文献求助30
2秒前
房东的猫完成签到,获得积分10
2秒前
okok发布了新的文献求助10
2秒前
大模型的应助被zz采纳,获得10
3秒前
王紫晴给王紫晴的求助进行了留言
3秒前
LI完成签到,获得积分10
4秒前
彭于晏的应助被远方采纳,获得10
4秒前
4秒前
5秒前
5秒前
细腻裙子完成签到,获得积分10
5秒前
5秒前
深情安青的应助被虞山小王子采纳,获得10
6秒前
李里完成签到,获得积分20
6秒前
能干储完成签到,获得积分10
6秒前
梁晓宇完成签到,获得积分10
7秒前
情怀的应助被wyyyy采纳,获得10
7秒前
奔跑的应助被likun采纳,获得40
8秒前
8秒前
TranYan完成签到,获得积分10
8秒前
9秒前
10秒前
10秒前
刘华珍完成签到,获得积分10
11秒前
11秒前
小巧惜芹完成签到 ,获得积分10
12秒前
gas发布了新的文献求助10
12秒前
wangzhenghua完成签到 ,获得积分10
12秒前
温珩完成签到,获得积分10
12秒前
13秒前
nnn发布了新的文献求助10
13秒前
木今完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182147
求助须知:如何正确求助?哪些是违规求助? 9571790
关于积分的说明 21820037
捐赠科研通 7778601
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479652